These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36276109)
1. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database. Wu Z; Qiu X; Zhi Y; Shi X; Lv G Front Oncol; 2022; 12():993524. PubMed ID: 36276109 [TBL] [Abstract][Full Text] [Related]
2. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation. Chen J; Yang Y; Liu Y; Kan H World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database. Qiu X; Cai J; Chen H; Yao J; Xiao C; Li R; Xiao J; Zhang J; Sui X; Lu T; Zheng J; Zhang Y; Yang Y Front Oncol; 2023; 13():1098686. PubMed ID: 37409255 [TBL] [Abstract][Full Text] [Related]
4. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis. Xie D; Qian B; Yang J; Peng X; Li Y; Hu T; Lu S; Chen X; Han Y Front Oncol; 2020; 10():598048. PubMed ID: 33194764 [TBL] [Abstract][Full Text] [Related]
5. Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting. Ye J; Wu H; Li J; Liu C Front Surg; 2022; 9():890564. PubMed ID: 36071950 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of total Yang Z; Tao Q; Mijiti S; Luo D; Tang X; Liu J; Jiang L; Liu Z; Liang C; Tu X; Zhao P; Luu AM; Serra F; Gelmini R; Wang Y; Zheng Y Ann Transl Med; 2022 May; 10(10):539. PubMed ID: 35722386 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article. Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623 [TBL] [Abstract][Full Text] [Related]
8. Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs). Wang Z; Cao F; Zhang Y; Fang Y; Li F Gastroenterol Res Pract; 2020; 2020():1946156. PubMed ID: 33061957 [TBL] [Abstract][Full Text] [Related]
9. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors. Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797 [TBL] [Abstract][Full Text] [Related]
10. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment. Wang B; Chen LJ; Wang XY Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587 [TBL] [Abstract][Full Text] [Related]
11. The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis. He CB; Zhang Y; Cai ZY; Lin XJ Endocr Connect; 2019 Mar; 8(3):239-251. PubMed ID: 30726772 [TBL] [Abstract][Full Text] [Related]
12. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database. Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X Front Oncol; 2020; 10():572462. PubMed ID: 33324549 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases. Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T Shi J; Liu S; Cao J; Shan S; Ren C; Zhang J; Wang Y Front Oncol; 2022; 12():899759. PubMed ID: 35574346 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study. Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035 [TBL] [Abstract][Full Text] [Related]
17. Second primary cancers and survival among neuroendocrine tumor patients. Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947 [TBL] [Abstract][Full Text] [Related]
19. Partial penectomy or total penectomy for T1 and T2 squamous cell carcinoma of the penis? Zheng QL; Wu YP; Zhang ZP; Xu N Transl Cancer Res; 2019 Sep; 8(5):1750-1755. PubMed ID: 35116925 [TBL] [Abstract][Full Text] [Related]
20. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors. Chen Q; Chen J; Huang Z; Zhao H; Cai J Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]